Substance abuse remains a prominent problem in the U.S. While the field of neuropharmacology has contributed substantially to the rapid advances in the science of addiction, the knowledge base required to design appropriate therapeutic modalities for substance abuse is incomplete. An obstacle to the continued progress of these efforts is the limited supply of creative, methodologically competent and dedicated scientists required to carry forward the effort into the 21st century. This request for continued funding of the Drug Abuse Training Program at the University of Texas Medical Branch capitalizes on a superb Program Faculty who exhibit multi-disciplinary research directions and methodological approaches that span from the examination of gene transcription to intracellular synaptic currents to the pharmacological analysis of drug discrimination mechanisms. The research directions of the Program Faculty extend over multiple neurotransmitters (e.g., excitatory/inhibitory amino acids, monoamines, acetylcholine) and neuro- modulators (e.g., CRF, opioids, hormones) and a multitude of methods, including molecular biology, electrophysiology, neurochemistry, and behavior. The present proposal is a request for continued funding of the Drug Abuse Training Program to educate pre- (N=2) and postdoctoral (N=2- 3) in the pharmacological and neural mechanisms of action of drugs of abuse for a period of 2-3 years. For predoctoral trainees, emphasis is initially placed upon imparting a rigorous academic background, an introduction to research concepts and methodologies via laboratory rotations followed by 2-3 years of original research on issues of primary importance to the elucidation of mechanisms by which drugs of abuse interact with neurotransmitters and influence neurotransmission. Postdoctoral trainees will concentrate on research throughout their training and will work closely with the Program Faculty who will facilitate the development of their scientific and professional careers. The present proposal draws upon the strengths of a multi-disciplinary faculty in pharmacology, toxicology and neuroscience to provide the scientific atmosphere in which students can develop an appreciation for the complex conceptual issues involved, the methodological approaches which can be applied, and the depth of the knowledge awaiting discovery. The only training grant on drug abuse in the expansive State of Texas is well positioned to generate a cadre of researchers dedicated to the study of substance abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
2T32DA007287-06
Application #
2801441
Study Section
Special Emphasis Panel (ZDA1-MXS-M (12))
Program Officer
Babecki, Beth
Project Start
1994-09-01
Project End
2004-06-30
Budget Start
1999-07-20
Budget End
2000-06-30
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Scala, Federico; Nenov, Miroslav N; Crofton, Elizabeth J et al. (2018) Environmental Enrichment and Social Isolation Mediate Neuroplasticity of Medium Spiny Neurons through the GSK3 Pathway. Cell Rep 23:555-567
Soto, Claudia A; Shashack, Matthew J; Fox, Robert G et al. (2018) Novel Bivalent 5-HT2A Receptor Antagonists Exhibit High Affinity and Potency in Vitro and Efficacy in Vivo. ACS Chem Neurosci 9:514-521
Miller, William R; Fox, Robert G; Stutz, Sonja J et al. (2018) PPAR? agonism attenuates cocaine cue reactivity. Addict Biol 23:55-68
Xu, Jimin; Wold, Eric A; Ding, Ye et al. (2018) Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection. Molecules 23:
Felsing, Daniel E; Anastasio, Noelle C; Miszkiel, Joanna M et al. (2018) Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction. PLoS One 13:e0203137
Kasper, J M; Milton, A J; Smith, A E et al. (2018) Cognitive deficits associated with a high-fat diet and insulin resistance are potentiated by overexpression of ecto-nucleotide pyrophosphatase phosphodiesterase-1. Int J Dev Neurosci 64:48-53
Price, Amanda E; Anastasio, Noelle C; Stutz, Sonja J et al. (2018) Serotonin 5-HT2C Receptor Activation Suppresses Binge Intake and the Reinforcing and Motivational Properties of High-Fat Food. Front Pharmacol 9:821
Price, Amanda E; Brehm, Victoria D; Hommel, Jonathan D et al. (2018) Pimavanserin and Lorcaserin Attenuate Measures of Binge Eating in Male Sprague-Dawley Rats. Front Pharmacol 9:1424
Cisneros, Irma E; Erdenizmenli, Mert; Cunningham, Kathryn A et al. (2018) Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes. Neuropharmacology 135:431-443
Neelakantan, Harshini; Holliday, Erica D; Fox, Robert G et al. (2017) Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats. ACS Chem Neurosci 8:1065-1073

Showing the most recent 10 out of 69 publications